Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Hyun‐Ae Jung"'
Publikováno v:
PloS one. 17(10)
Background Oropharyngeal squamous cell carcinoma (OPSCC) is the most common neoplasm originating at the base of the tongue or in the tonsils or soft palate. In this study, we investigated the prognostic value of FOXP3+ regulatory T cells in OPSCC. Me
Autor:
Hyun Ae Jung, Jinyeong Lim, Yoon-La Choi, Se-Hoon Lee, Je-Gun Joung, Yeong Jeong Jeon, Jae Won Choi, Sumin Shin, Jong Ho Cho, Hong Kwan Kim, Yong Soo Choi, Jae Ill Zo, Young Mog Shim, Sehhoon Park, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Joungho Han, Woong-Yang Park, Jhingook Kim, Keunchil Park
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 28(19)
Purpose: In early-stage, EGFR mutation–positive (EGFR-M+) non–small cell lung cancer (NSCLC), surgery remains the primary treatment, without personalized adjuvant treatments. We aimed to identify risk factors for recurrence-free survival (RFS) to
Publikováno v:
Cancer immunology, immunotherapy : CII. 70(5)
Nivolumab, a programmed death 1 (PD-1) inhibitor, has recently demonstrated efficacy as second-line therapy for esophageal squamous cell carcinoma (ESCC) patients in a phase III trial. We report real-world clinical outcomes of nivolumab therapy for E
Autor:
Jin Seok Ahn, Hyun Ae Jung, Yoon-La Choi, Keunchil Park, Ji Yun Lee, Myung-Ju Ahn, Se-Hoon Lee, Jong-Mu Sun
Publikováno v:
European journal of cancer (Oxford, England : 1990). 132
Background We evaluated programmed death ligand 1 (PD-L1) expression and efficacy of PD-1/PD-L1 inhibitors in patients with pulmonary pleomorphic carcinoma (PC). Methods We created two cohorts of patients diagnosed with pulmonary PC from 2016 to 2019
Publikováno v:
Annals of Laboratory Medicine
Background The identification of genetic abnormalities in patients with multiple myeloma (MM) has gained emphasis because genetics-based risk stratification significantly affects overall survival (OS). We investigated genetic abnormalities using conv
Autor:
Hyun Ae Jung, Keunchil Park, Boram Lee, Myung-Ju Ahn, Seonggyu Byeon, Yoon-La Choi, Woong-Yang Park, Se-Hoon Lee, Jin Seok Ahn, Jong-Mu Sun
Publikováno v:
Clinical lung cancer. 21(3)
Background Genetic sequencing testing has become widely used to inform treatment decisions for advanced non-small cell lung cancer (NSCLC) patients. We analyzed benefits of genetic sequencing testing in real practice. Methods We retrospectively revie
Autor:
Hyun Ae Jung, Moon Jin Kim, Young-Hyuck Im, Won Ho Kil, Yeon Hee Park, Sung-min Kim, Jin Seok Ahn, Jeong Eon Lee, Seok Jin Nam, Su Jin Lee
Publikováno v:
The Breast. 24:213-217
The purpose of our study was to investigate and identify comprehensively the clinicopathological features and long-term outcome of young breast cancer (YBC) according to intrinsic subtype. We analyzed clinical and pathological characteristics of 2844
Autor:
Seok Jin Kim1 kstwoh@skku.edu, Hyun Ae Jung1 hyunae.jung@samsung.com, Shih-Sung Chuang2 Cmh5301@mail.chimei.org.tw, Huangming Hong3 honghm@sysucc.org.cn, Cheng-Cheng Guo3 guochch@sysucc.org.cn, Junning Cao4 cao_junning@hotmail.com, Xiao-Nan Hong4 xnhong@126.com, Ritsuro Suzuki5 r-suzuki@med.nagoya-u.ac.jp, Hye Jin Kang6 hyejin@kcch.re.kr, Jong Ho Won7 jhwon@schmc.ac.kr, Wee-Joo Chng8 mdccwj@nus.edu.sg, Yok-Lam Kwong9 ylkwong@hkucc.hku.hk, Cheolwon Suh10 csuh@amc.seoul.kr, Yu-Qin Song11 songyuqin622@sina.com, Jun Zhu11 zj@bjcancer.org, Kevin Tay12 kevin.tay.k.w@nccs.com.sg, Soon Thye Lim12 soonthyelim@yahoo.com, Junji Suzumiya13 suzumiya@med.shimane-u.ac.jp, Tong-Yu Lin3 TongyuLim@hotmail.com, Won Seog Kim1 wskimsmc@skku.edu
Publikováno v:
Journal of Hematology & Oncology. 2013, Vol. 6 Issue 1, p1-18. 18p.
Autor:
Joonghyun Ahn, Hyun Ae Jung, Yunseon Choi, Misun Choi, W. Chang, In-Gu Do, Yunjoo Im, Young-Ae Park
Publikováno v:
British Journal of Cancer
Background: The aim of this study was to investigate the role of human epidermal growth factor receptor (HER3) and PTEN expression in patients with HER2-overexpressing metastatic breast cancer (MBC). Methods: One hundred twenty-five MBC patients who
Autor:
Jung Yong, Hong, Ja-Young, Seo, Sun-Hee, Kim, Hyun Ae, Jung, Silvia, Park, Kihyun, Kim, Chul Won, Jung, Jin Seok, Kim, Joon Seong, Park, Hee-Jin, Kim, Jun Ho, Jang
Publikováno v:
Anticancer research. 35(5)
Hypomethylating agents, such as azacitidine and decitabine, now constitute one of the mainstays of myelodysplastic syndrome (MDS) treatment. In recent years, novel recurrent mutations in multiple genes encoding RNA spliceosomal machinery (SRSF2, U2AF